ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2282

Performance Of The 2010 ACR/EULAR Classification Criteria For Rheumatoid Arthritis In a Group Of Elderly Onset Patients

Pierluigi Macchioni1, Giovanni Barausse2, Luigi Boiardi1, Giulia Pazzola1, Roberto Bortolotti2, Giovanna Restuccia1, Maria Grazia Catanoso1, Giuseppe Paolazzi3 and Carlo Salvarani4, 1Rheumatology Service, Arcispedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, 2Rheumatology, Ospedale di Trento, Trento, Italy, 3Rheumatology, Ospedale Santa Chiara, Trento, Italy, 4Rheumatology, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: classification criteria, Elderly, performance, polymyalgia rheumatica and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis-Clinical Aspects III: Outcome Measures, Socioeconomy, Screening, Biomarkers in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: To evaluate the diagnostic ability of the 2010 ACR/EULAR classification criteria for Rheumatoid arthritis (RA) in a consecutive series of elderly onset (> 50y) RA (EORA) in comparison with a group of new onset polymyalgia rheumatica (PMR) patients.

Methods: All patients with early arthritis seen at our two centres are followed according to a standardized protocol which include clinical examination (including 66 joint count), determination of laboratory parameters, QOL questionnaire, X-ray examination of hands and feet. Consecutive patients seen in our rheumatological centres with recent onset arthritis and followed for at least 12 months were included prospectively during a 5 year period. Patients entered the study if diagnosis of RA or PMR were confirmed at 12 month follow-up period according to rheumatologist opinion (PM, GB). Diagnostic performance of  ACR/EULAR 2010 classification criteria were evaluated and compared in the two groups of patients

Results: 144 new EORA and 137 new onset PMR patients entered the study. Table 1 compare demographic, clinical and laboratory data between the two populations.

Conclusion: In a group of new onset EORA patients ACR/EULAR 2010 RA classification criteria have 66.2% sensitivity. ACR/EULAR 2010 criteria have high specificity and could be used to exclude RA in a new onset PMR patients

Table 1. Demographic, clinical and laboratory characteristics of  the patients at first examination.

 

EORA

PMR

p

Difference (95%CI)

Mean Age (y)

64.6+9.2

74.5+7.4

< 0.001

9.4(7.5-11.4)

Male/female

27/73

29/71

ns

 

Mean Disease duration (Weeks)

13+12

13+19

ns

0.7(-4.6-3.2)

ESR (mm/first hour)

41+26

60+24

< 0.001

18 (12-24)

CRP (mg/dl)

2.5+3.2

5.1+4.3

< 0.001

2.5 (1.6-3.4)

RF/ACPA +

49%

1%

< 0.001

 

 

 

 

 

 

Mean large joint involved

1.6+1.7

3.38+1

< 0.001

1.7(1.5-2)

Mean small Joint Involved

7.4+5.6

1+1

< 0.001

6.5(7.5-5.5)

Mean ACR/EULAR points

6.3+1.9

3.4+1

< 0.001

3 (3.3-2.4)

ACR/EULAR positivity

66.2%

3.2%

< 0.001

OR 48.9 (14-163)


Disclosure:

P. Macchioni,
None;

G. Barausse,
None;

L. Boiardi,
None;

G. Pazzola,
None;

R. Bortolotti,
None;

G. Restuccia,
None;

M. G. Catanoso,
None;

G. Paolazzi,
None;

C. Salvarani,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/performance-of-the-2010-acreular-classification-criteria-for-rheumatoid-arthritis-in-a-group-of-elderly-onset-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology